New combination treatment brings hope to advanced bladder cancer patients
Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated that a combination treatment of fibroblast growth factor receptor (FGFR) inhibitor and programmed cell death ligand 1 (PD-L1) inhibitor is safe and tolerable in …